4//SEC Filing
Yablonka Uri 4
Accession 0001104659-20-021985
CIK 0001137883other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:00 PM ET
Size
5.9 KB
Accession
0001104659-20-021985
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2019-12-12+13,333→ 13,333 totalExercise: $0.75From: 2020-01-12Exp: 2029-12-12→ Common Stock (13,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on January 12, 2020 until fully vested and exercisable on December 12, 2020, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001608814
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:00 PM ET
- Size
- 5.9 KB